#1
Posted: Mon Apr 06, 2026 6:00 pm
Originally developed to treat diabetes, a class of drugs known as glucagon-like peptide-1 receptor agonists (GLP-1 RAs) are now stepping into the spotlight as weight loss drugs. A recent umbrella review draws attention to safety concerns regarding the use of this GLP medication, alongside a mix of potential benefits.
Source: https://medicalxpress.com/news/2026-04- ... -side.html
Source: https://medicalxpress.com/news/2026-04- ... -side.html